Jang-Ho Cha in

Jang-Ho Cha

Login to view DISC.
Chief Scientific Officer & Chief Medical Officer at Latus Bio
📍 Cambridge, Massachusetts, United States

Jang-Ho Cha is the Chief Scientific and Medical Officer at Latus Bio, leading the development of gene therapies for neurodegenerative disorders. An MD/PhD from the University of Michigan, he has held senior roles at Novartis and Merck, focusing on translational neuroscience. People who have worked with him describe him as knowledgeable, decisive, and efficient.

His career is deeply intertwined with patient advocacy, particularly for Huntingtons disease (HD). He has served as the Chairman of the Board for the Huntingtons Disease Society of America, reflecting a profound commitment to unifying patients, families, and medical professionals to combat the disease and provide hope.

Unique fact: Dr. Cha was part of the scientific team that helped discover the HTT gene, the gene responsible for Huntingtons Disease.

Read the full overview →
Experience
31 Years
Current Role
Chief Scientific Officer & Chief Medical Officer
Job Level
Leadership
Location
Cambridge, Massachusetts, United States
Personality Overview

How Jang-Ho shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Jang-Ho cares about

Huntington's Disease
He has dedicated his career to HD, serving as Board Chair for the HDSA and was part of the team that discovered the causative HTT gene.
Gene Therapy
His work at Latus Bio is focused on developing novel AAV capsids to deliver genetic material more effectively to deep brain structures for treating CNS diseases.
+4 more topics Login to view topics
Career

Work history

12-2022
Chief Scientific Officer & Chief Medical Officer
Latus Bio
12-2014 - 12-2022
Global Translational Medicine Head, Neuroscience
Novartis Institutes for BioMedical Research
12-2014 - 12-2016
Chair Board of Trustees
Huntington's Disease Society of America
7-2014 - 12-2014
Head, Discovery Medicine
Merck
11-2013 - 12-2014
Neuroscience Lead, Discovery Medicine
Merck
In the press

Media appearances

Latus Bio Announces Data Presentations in Support of its Preclinical Huntington’s Disease Gene‑Therapy Program. Featured in Business Wire
See now
Buzzin' w/ Jang-Ho Cha, Chief Scientific & Medical Officer, Latus Bio. Featured in YouTube
+1 more appearances Login to view media
Education
1984 - 1991
M.D. and Ph.D
University of Michigan
1984 - 1991
MD
University of Michigan Medical School
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Jang-Ho. Free, 10 seconds.